Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | FASN | P49327 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28862954 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3129774 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3129770 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3128974 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL17540807 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL8345723 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL6598890 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3128979 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL13725844 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL21518030 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109890832-B | Semi-biosynthetic production of fatty alcohols and fatty aldehydes | 普罗维维股份有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20220136018-A1 | SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES | HORIZON TECHNOLOGY FINANCE CORPORATION | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220136018-A1 | SEMI-BIOSYNTHETIC PRODUCTION OF FATTY ALCOHOLS AND FATTY ALDEHYDES | FASN, FAR1, COASY | PPARA 508/4885PTPN1 4274/4885ACHE 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.